Jane Street
BBIO icon

Jane Street’s BridgeBio Pharma BBIO Stock Holding History

Jane Street’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$219M Buy
2,934,193
+1,176,521
+67% +$82.4M 0.02% 541
2026
Q1 		$131M Buy
1,757,672
+1,415,877
+414% +$103M 0.02% 532
2025
Q4 		$26.1M Sell
341,795
-292,091
-46% -$19.2M ﹤0.01% 1382
2025
Q3 		$32.9M Buy
633,886
+129,544
+26% +$6.32M 0.01% 1219
2025
Q2 		$21.8M Sell
504,342
-334,016
-40% -$12.1M ﹤0.01% 1373
2025
Q1 		$29M Buy
838,358
+173,434
+26% +$5.85M 0.01% 1018
2024
Q4 		$18.2M Buy
664,924
+140,563
+27% +$3.63M ﹤0.01% 1332
2024
Q3 		$13.4M Sell
524,361
-192,824
-27% -$5.06M ﹤0.01% 1624
2024
Q2 		$18.2M Buy
717,185
+487,609
+212% +$13.3M ﹤0.01% 1408
2024
Q1 		$7.1M Sell
229,576
-6,854
-3% -$233K ﹤0.01% 2179
2023
Q4 		$9.54M Sell
236,430
-80,852
-25% -$2.43M ﹤0.01% 2009
2023
Q3 		$8.37M Sell
317,282
-27,412
-8% -$778K ﹤0.01% 1983
2023
Q2 		$5.93M Buy
344,694
+184,682
+115% +$2.78M ﹤0.01% 2508
2023
Q1 		$2.65M Buy
160,012
+105,954
+196% +$1.24M ﹤0.01% 3356
2022
Q4 		$412K Buy
54,058
+33,883
+168% +$324K ﹤0.01% 6472
2022
Q3 		$201K Sell
20,175
-60,373
-75% -$627K ﹤0.01% 8173
2022
Q2 		$731K Buy
80,548
+58,056
+258% +$486K ﹤0.01% 6047
2022
Q1 		$228K Sell
22,492
-149,845
-87% -$1.54M ﹤0.01% 8837
2021
Q4 		$2.87M Buy
172,337
+133,197
+340% +$5.64M ﹤0.01% 3765
2021
Q3 		$1.83M Buy
39,140
+28,278
+260% +$1.52M ﹤0.01% 4648
2021
Q2 		$662K Buy
10,862
+2,050
+23% +$117K ﹤0.01% 6703
2021
Q1 		$543K Sell
8,812
-36,478
-81% -$2.39M ﹤0.01% 6649
2020
Q4 		$3.22M Buy
45,290
+15,307
+51% +$738K ﹤0.01% 2732
2020
Q3 		$1.13M Buy
29,983
+20,506
+216% +$645K ﹤0.01% 3906
2020
Q2 		$309K Buy
+9,477
New +$289K ﹤0.01% 5790

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Jane Street's BBIO Position: Q2 2026 in Review

Jane Street increased its BridgeBio Pharma (BBIO) stake by 67% in Q2 2026, buying an estimated $82.4M and bringing the position to 2,934,193 shares worth $219M. The position accounts for 0.02% of the portfolio, ranked #541.

Jane Street first reported a position in BBIO in Q2 2020 and has held it in 25 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Jane Street held 2,934,193 shares of BridgeBio Pharma worth $219M as of Q2 2026.
  • Jane Street bought 1,176,521 BridgeBio Pharma shares in Q2 2026, an estimated $82.4M.
  • BridgeBio Pharma made up 0.02% of Jane Street's portfolio in Q2 2026, its #541 holding.
  • Jane Street first reported a position in BridgeBio Pharma in Q2 2020 and has held it in 25 quarters since.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.